Drugs News and Research

RSS

Genervon generates biomarker data for its Phase 2a clinical trial for ALS

Genervon Biopharmaceuticals LLC ("Genervon") today announced that it has analyzed and generated a Biomarker Data Report for its recent Phase 2a clinical trial for ALS disease modification.

30 Jun 2014

Conventional fertility hormones do not increase risk of breast, gynecological cancers

There is "little evidence" that the use of conventional fertility hormones used for ovarian stimulation in the treatment of infertility increases the long-term risk of breast and gynecological cancers, according to the results of a substantial 30-year follow-up study.

30 Jun 2014

First Edition: June 30, 2014

Today's early morning highlights from the major news organizations, including an announcement coming today for a new VA secretary and expectations for a Supreme Court decision on the challenge to the health law's contraceptive mandate by two for-profit companies.

30 Jun 2014

Sexting linked to sexual behavior in early adolescence

A study from USC researchers provides new understanding of the relationship between "sexting" and sexual behavior in early adolescence, contributing to an ongoing national conversation about whether sexually explicit text messaging is a risk behavior or just a technologically-enabled extension of normal teenage flirtation. The latest research, published in the July 2014 issue of the journal Pediatrics, found that among middle school students, those who reported receiving a sext were 6 times more likely to also report being sexually active.

30 Jun 2014

patients with KRAS wild-type MCRC can benefit from Cetuximab Or Bevacizumab With Combi Chemo Equivalent For patients with KRAS wild-type MCRC

For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona.

30 Jun 2014

Karolinska Institute Professor calls for innovative solutions for global healthcare

Einstein once observed that "it is harder to crack prejudice than an atom". If he was right, then Hans Rosling is faced with a labour of Hercules.

28 Jun 2014

Host-directed therapy: A new type of TB treatment

In a new study published in Nature, scientists describe a new type of tuberculosis (TB) treatment that involves manipulating the body's response to TB bacteria rather than targeting the bacteria themselves, a concept called host-directed therapy.

28 Jun 2014

CNIO researchers identify over 40 genes that predict aggressiveness of melanoma

Researchers from the Spanish National Cancer Research Centre have discovered more than 40 genes that predict the level of aggressiveness of melanoma and that distinguish it from other cancers with a poor prognosis. The discovery, published in Cancer Cell, will help to identify unique aspects of melanoma that could contribute to determine the risk of developing metastasis in patients with this disease.

28 Jun 2014

Targeting ASIC-related neurotransmission may lead to new therapies for treating drug addiction

University of Iowa researchers have discovered a new form of neurotransmission that influences the long-lasting memory created by addictive drugs, like cocaine and opioids, and the subsequent craving for these drugs of abuse. Loss of this type of neurotransmission creates changes in brains cells that resemble the changes caused by drug addiction.

28 Jun 2014

Lassa virus uses two-step process to invade cells, shows study

Scientists have discovered that the Lassa virus, which is endemic to West Africa, uses an unexpected two-step process to enter cells.

28 Jun 2014

Newly identified compound may halt progression of Alzheimer's disease

Without a steady supply of blood, neurons can't work. That's why one of the culprits behind Alzheimer's disease is believed to be the persistent blood clots that often form in the brains of Alzheimer's patients, contributing to the condition's hallmark memory loss, confusion and cognitive decline.

28 Jun 2014

University of Louisville researchers take a step forward in battle against lung cancer

Researchers at the University of Louisville have uncovered a cadre of small molecules that tell certain proteins to kill lung cancer cells. The team, led by Chi Li, Ph.D., assistant professor of medicine, published its finding in the April 2014 issue of Molecular and Cellular Biology.

28 Jun 2014

Researchers give new, unprecedented 3-D view of most important brain receptors

Researchers with Oregon Health & Science University's Vollum Institute have given science a new and unprecedented 3-D view of one of the most important receptors in the brain - a receptor that allows us to learn and remember, and whose dysfunction is involved in a wide range of neurological diseases and conditions, including Alzheimer's, Parkinson's, schizophrenia and depression.

28 Jun 2014

European approval process for Eckert & Ziegler’s gallium-68 generator is successfully completed

Eckert & Ziegler Radiopharma GmbH has received a recommendation from the European Medicines Agency for approval of its pharmaceutical 68Ge/68Ga generators.

28 Jun 2014

Weak hospice oversight makes safety problems hard to identify

The typical hospice undergoes a full government inspection about once every six years, according to The Washington Post, making it one of the least scrutinized areas of U.S. health care.

28 Jun 2014

Afrezza gets FDA approval to improve glycemic control in adults with diabetes mellitus

The U.S. Food and Drug Administration today approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal, or within 20 minutes after starting a meal.

28 Jun 2014

Some cancer patients with aggressive tumors may benefit from anti-inflammatory drugs

New research raises the prospect that some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs used to treat rheumatoid arthritis.

28 Jun 2014

First step toward new drugs that can transcend antibiotic resistance issues

Scientists in the United States and India have successfully modified the precursor to one of the drugs used to treat tuberculosis, an important first step toward new drugs that can transcend antibiotic resistance issues that experts consider a serious threat to global health.

28 Jun 2014

Sleep problems associated with worse memory and executive function in older people

Research published today in PLOS ONE by researchers at the University of Warwick indicates that sleep problems are associated with worse memory and executive function in older people.

28 Jun 2014

Ohm receives U.S. FDA approval to manufacture and market Valsartan

Ohm Laboratories, Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited, announced today that Ohm has received approval from the U.S. Food and Drug Administration to manufacture and market Valsartan 40 mg, 80 mg, 160 mg, and 320 mg tablets on an exclusive basis.

27 Jun 2014

Drugs News and Research

Genervon generates biomarker data for its Phase 2a clinical trial for ALS

Conventional fertility hormones do not increase risk of breast, gynecological cancers

First Edition: June 30, 2014

Sexting linked to sexual behavior in early adolescence

patients with KRAS wild-type MCRC can benefit from Cetuximab Or Bevacizumab With Combi Chemo Equivalent For patients with KRAS wild-type MCRC

Karolinska Institute Professor calls for innovative solutions for global healthcare

Host-directed therapy: A new type of TB treatment

CNIO researchers identify over 40 genes that predict aggressiveness of melanoma

Targeting ASIC-related neurotransmission may lead to new therapies for treating drug addiction

Lassa virus uses two-step process to invade cells, shows study

Newly identified compound may halt progression of Alzheimer's disease

University of Louisville researchers take a step forward in battle against lung cancer

Researchers give new, unprecedented 3-D view of most important brain receptors

European approval process for Eckert & Ziegler’s gallium-68 generator is successfully completed

Weak hospice oversight makes safety problems hard to identify

Afrezza gets FDA approval to improve glycemic control in adults with diabetes mellitus

Some cancer patients with aggressive tumors may benefit from anti-inflammatory drugs

First step toward new drugs that can transcend antibiotic resistance issues

Sleep problems associated with worse memory and executive function in older people

Ohm receives U.S. FDA approval to manufacture and market Valsartan

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News